RE:Review the November 29 news releaseAlthough calculating intrinsic value can be very subjective depending on what qualitative and quantitive factors are being used, your numbers tend to match a similar stock price that I have calculated again and again. There's absolutely no doubt this stock is way undervalued. The trailing 12 month revenue for this stock is $52-53 million and at the current share price it is literally trading at 1x revenue for those trailing 12 months. Completely ridiculous! More importantly, the company has a completely clean balance sheet
and lots of future growth and additional revenue to come.
As for Astutein, he can be ignored completely. He only pops up around here to bash the stock when it pulls back. Meanwhile he's busy pumping a stock that has an EPS of -0.21, is down year over year in financial revenue, gross margin is down, consolidated adjusted EBITDA has taken a severe hit, cash and cash equilvalents down majorly, just added a $57.5 million convertible debenture to their balance sheet and appears to be in litigation. It's amazing the hypocracy of an individual who pops up to bash a stock with a "squeaky clean" balance sheet and a positive EPS while pumping one that is completely the opposite.